Glenmark Pharmaceuticals Limited Share Price Bombay S.E.
Stocks
GLENMARK
INE935A01035
Pharmaceuticals
|
Market Closed -
Bombay S.E.
03:32:32 06/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,288.95 INR | +0.32% |
|
-2.01% | +12.43% |
| 11/09 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 07/09 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
| Market Cap | 65TCr 676.82Cr 601.04Cr 563.15Cr 509.86Cr 961.68Cr 969.77Cr 6.76TCr 2.63TCr 33TCr 2.54TCr 2.49TCr 1,07100Cr | P/E 2027 * |
28.2x | P/E 2028 * | 23.5x |
|---|---|---|---|---|---|
| Enterprise Value | 62TCr 638.95Cr 567.41Cr 531.64Cr 481.34Cr 907.88Cr 915.51Cr 6.39TCr 2.48TCr 31TCr 2.4TCr 2.35TCr 1,01100Cr | EV / Sales 2027 * |
3.66x | EV / Sales 2028 * | 3.22x |
| Free-Float |
51.04% | Yield 2027 * |
0.17% | Yield 2028 * | 0.17% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLENMARK | Delayed | |
Bombay S.E.
| GLENMARK | Delayed |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +0.32% | ||
| 1 week | -2.01% | ||
| Current month | -0.91% | ||
| 1 month | -5.69% | ||
| 3 months | +3.58% | ||
| 6 months | +9.29% | ||
| Current year | +12.43% |
| 1 week | 2,273.7 |  | 2,413.4 |
| 1 month | 2,273.7 | | 2,491.2 |
| Current year | 1,842.8 | | 2,536.85 |
| 1 year | 1,794 | | 2,536.85 |
| 3 years | 702.05 | | 2,536.85 |
| 5 years | 348.9 | | 2,536.85 |
| 10 years | 168 | | 2,536.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 86 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.32% | -2.01% | - | - | 672.49Cr | |
| +1.26% | -2.30% | +37.82% | +113.76% | 1,01900Cr | |
| +0.73% | -6.31% | +35.06% | +62.14% | 61TCr | |
| +0.35% | +0.15% | +14.01% | +80.87% | 47TCr | |
| +1.72% | -4.54% | +59.14% | +37.01% | 34TCr | |
| +0.26% | -1.58% | +21.97% | +41.79% | 34TCr | |
| +0.60% | -3.48% | +11.37% | +34.33% | 27TCr | |
| +1.65% | -4.27% | -5.47% | +9.69% | 24TCr | |
| -0.09% | -3.71% | +35.15% | +51.88% | 22TCr | |
| -0.28% | -5.24% | +27.99% | +93.08% | 18TCr | |
| Average | +0.43% | -3.63% | +26.34% | +58.28% | 40.92TCr | |
| Weighted average by Cap. | +0.41% | -3.51% | +29.49% | +70.06% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 17TCr 174.67Cr 155.11Cr 145.33Cr 131.58Cr 248.18Cr 250.27Cr 1.75TCr 677.68Cr 8.59TCr 655.58Cr 641.51Cr 28TCr | 19TCr 194.42Cr 172.66Cr 161.77Cr 146.46Cr 276.26Cr 278.58Cr 1.94TCr 754.34Cr 9.56TCr 729.74Cr 714.08Cr 31TCr |
| Net income | 2.33TCr 24Cr 22Cr 20Cr 18Cr 34Cr 35Cr 242.12Cr 94Cr 1.19TCr 91Cr 89Cr 3.83TCr | 2.8TCr 29Cr 26Cr 24Cr 22Cr 41Cr 42Cr 290.15Cr 112.64Cr 1.43TCr 108.96Cr 106.63Cr 4.59TCr |
| Net Debt | -3.65TCr -38Cr -34Cr -32Cr -29Cr -54Cr -54Cr -378.48Cr -146.93Cr -1.86TCr -142.14Cr -139.09Cr -5.99TCr | -4.8TCr -50Cr -44Cr -41Cr -38Cr -71Cr -71Cr -497.89Cr -193.28Cr -2.45TCr -186.98Cr -182.97Cr -7.88TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | ₹2,288.95 | +0.32% | 13,398 |
| 05/26/05 | ₹2,281.60 | -2.34% | 15,494 |
| 01/26/01 | ₹2,336.30 | +1.14% | 35,968 |
| 30/26/30 | ₹2,309.90 | -3.55% | 31,273 |
| 29/26/29 | ₹2,395.00 | +2.53% | 36,513 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
